Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Nov;69(5 Spec No):505–509. doi: 10.1136/adc.69.5_spec_no.505

Growth retardation after dexamethasone administration: assessment by knemometry.

A T Gibson 1, R G Pearse 1, J K Wales 1
PMCID: PMC1029593  PMID: 8285754

Abstract

Knemometry has been used to measure lower leg growth during 32 nine day courses of dexamethasone in 26 babies ranging from 24 to 32 weeks' gestation at birth. Mean leg length velocity was 0.37 mm/day in the 10 days before steroids. Administration of dexamethasone was associated with a decrease in velocity in all babies, and in 15 leg shortening was documented. Mean leg length velocity during steroid treatment was -0.003 mm/day. After the course of dexamethasone was completed there was an immediate increase in leg length velocity to a mean of 0.52 mm/day over the first 10 days then falling to a value similar to the growth velocity observed before treatment. Leg length had reached the value predicted by growth before steroids about 30 days after dexamethasone. The reduction in leg length velocity occurred despite a significant increase in energy intake and decrease in oxygen requirements.

Full text

PDF
505

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballard P. L., Gluckman P. D., Liggins G. C., Kaplan S. L., Grumbach M. M. Steroid and growth hormone levels in premature infants after prenatal betamethasone therapy to prevent respiratory distress syndrome. Pediatr Res. 1980 Feb;14(2):122–127. doi: 10.1203/00006450-198002000-00011. [DOI] [PubMed] [Google Scholar]
  2. Benini F., Rubaltelli F. F., Griffith P., Sala M., Zorzi C. Dexamethasone in the treatment of bronchopulmonary dysplasia. Acta Paediatr Scand Suppl. 1989;360:108–112. doi: 10.1111/j.1651-2227.1989.tb11290.x. [DOI] [PubMed] [Google Scholar]
  3. Bozynski M. E., Albert J. M., Vasan U., Nelson M. N., Zak L. K., Naughton P. M. Bronchopulmonary dysplasia and postnatal growth in extremely premature black infants. Early Hum Dev. 1990 Feb;21(2):83–92. doi: 10.1016/0378-3782(90)90037-j. [DOI] [PubMed] [Google Scholar]
  4. Brook C. G., Hindmarsh P. C., Stanhope R. Growth and growth hormone secretion. J Endocrinol. 1988 Nov;119(2):179–184. doi: 10.1677/joe.0.1190179. [DOI] [PubMed] [Google Scholar]
  5. Brownlee K. G., Ng P. C., Henderson M. J., Smith M., Green J. H., Dear P. R. Catabolic effect of dexamethasone in the preterm baby. Arch Dis Child. 1992 Jan;67(1 Spec No):1–4. doi: 10.1136/adc.67.1_spec_no.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cummings J. J., D'Eugenio D. B., Gross S. J. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989 Jun 8;320(23):1505–1510. doi: 10.1056/NEJM198906083202301. [DOI] [PubMed] [Google Scholar]
  7. Fisher D. A., Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev. 1990 Aug;11(3):418–442. doi: 10.1210/edrv-11-3-418. [DOI] [PubMed] [Google Scholar]
  8. Harkavy K. L., Scanlon J. W., Chowdhry P. K., Grylack L. J. Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial. J Pediatr. 1989 Dec;115(6):979–983. doi: 10.1016/s0022-3476(89)80754-1. [DOI] [PubMed] [Google Scholar]
  9. Harkness E. M. Growth spurts in transplanted rat humeri in adult hosts. Prog Clin Biol Res. 1982;101:379–392. [PubMed] [Google Scholar]
  10. Hermanussen M. Knemometry, a new tool for the investigation of growth. A review. Eur J Pediatr. 1988 May;147(4):350–355. doi: 10.1007/BF00496409. [DOI] [PubMed] [Google Scholar]
  11. Kao L. C., Durand D. J., Nickerson B. G. Improving pulmonary function does not decrease oxygen consumption in infants with bronchopulmonary dysplasia. J Pediatr. 1988 Apr;112(4):616–621. doi: 10.1016/s0022-3476(88)80184-7. [DOI] [PubMed] [Google Scholar]
  12. Kaplowitz P. B. Glucocorticoids enhance somatomedin-C binding and stimulation of amino acid uptake in human fibroblasts. J Clin Endocrinol Metab. 1987 Mar;64(3):563–571. doi: 10.1210/jcem-64-3-563. [DOI] [PubMed] [Google Scholar]
  13. Kazzi N. J., Brans Y. W., Poland R. L. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics. 1990 Nov;86(5):722–727. [PubMed] [Google Scholar]
  14. Kurzner S. I., Garg M., Bautista D. B., Bader D., Merritt R. J., Warburton D., Keens T. G. Growth failure in infants with bronchopulmonary dysplasia: nutrition and elevated resting metabolic expenditure. Pediatrics. 1988 Mar;81(3):379–384. [PubMed] [Google Scholar]
  15. Kurzner S. I., Garg M., Bautista D. B., Sargent C. W., Bowman C. M., Keens T. G. Growth failure in bronchopulmonary dysplasia: elevated metabolic rates and pulmonary mechanics. J Pediatr. 1988 Jan;112(1):73–80. doi: 10.1016/s0022-3476(88)80126-4. [DOI] [PubMed] [Google Scholar]
  16. Lindroth M., Mortensson W. Long-term follow-up of ventilator treated low birthweight infants. I. Chest X-ray, pulmonary mechanics, clinical lung disease and growth. Acta Paediatr Scand. 1986 Sep;75(5):819–826. doi: 10.1111/j.1651-2227.1986.tb10296.x. [DOI] [PubMed] [Google Scholar]
  17. Mammel M. C., Fiterman C., Coleman M., Boros S. J. Short-term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and 1-year follow-up. Dev Pharmacol Ther. 1987;10(1):1–11. doi: 10.1159/000457722. [DOI] [PubMed] [Google Scholar]
  18. Mammel M. C., Green T. P., Johnson D. E., Thompson T. R. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet. 1983 Jun 18;1(8338):1356–1358. doi: 10.1016/s0140-6736(83)92139-6. [DOI] [PubMed] [Google Scholar]
  19. Michaelsen K. F., Skov L., Badsberg J. H., Jørgensen M. Short-term measurement of linear growth in preterm infants: validation of a hand-held knemometer. Pediatr Res. 1991 Nov;30(5):464–468. doi: 10.1203/00006450-199111000-00013. [DOI] [PubMed] [Google Scholar]
  20. Noble-Jamieson C. M., Regev R., Silverman M. Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications. Eur J Pediatr. 1989 Jan;148(4):365–367. doi: 10.1007/BF00444135. [DOI] [PubMed] [Google Scholar]
  21. Rimsza M. E. Complications of corticosteroid therapy. Am J Dis Child. 1978 Aug;132(8):806–810. doi: 10.1001/archpedi.1978.02120330078018. [DOI] [PubMed] [Google Scholar]
  22. Rodriguez J. I., Razquin S., Palacios J., Rubio V. Human growth plate development in the fetal and neonatal period. J Orthop Res. 1992 Jan;10(1):62–71. doi: 10.1002/jor.1100100108. [DOI] [PubMed] [Google Scholar]
  23. SILVERMAN W. A., DAY R. L., BLODI F. C. Inhibition of growth and other effects of ACTH in premature infants. Pediatrics. 1951 Aug;8(2):177–191. [PubMed] [Google Scholar]
  24. Sauve R. S., Singhal N. Long-term morbidity of infants with bronchopulmonary dysplasia. Pediatrics. 1985 Nov;76(5):725–733. [PubMed] [Google Scholar]
  25. Silbermann M., von der Mark K., Maor G., van Menxel M. Dexamethasone impairs growth and collagen synthesis in condylar cartilage in vitro. Bone Miner. 1987 Apr;2(2):87–106. [PubMed] [Google Scholar]
  26. Unterman T. G., Phillips L. S. Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab. 1985 Oct;61(4):618–626. doi: 10.1210/jcem-61-4-618. [DOI] [PubMed] [Google Scholar]
  27. Valk I. M., Chabloz A. M., Smals A. G., Kloppenborg P. W., Cassorla F. G., Schutte E. A. Accurate measurements of the lower leg length and the ulnar length and its application in short term growth measurement. Growth. 1983 Spring;47(1):53–66. [PubMed] [Google Scholar]
  28. Wales J. K., Milner R. D. Knemometry in assessment of linear growth. Arch Dis Child. 1987 Feb;62(2):166–171. doi: 10.1136/adc.62.2.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Weinstein M. R., Oh W. Oxygen consumption in infants with bronchopulmonary dysplasia. J Pediatr. 1981 Dec;99(6):958–961. doi: 10.1016/s0022-3476(81)80032-7. [DOI] [PubMed] [Google Scholar]
  30. Williams A. F., Jones M. Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia. Arch Dis Child. 1992 Jan;67(1 Spec No):5–9. doi: 10.1136/adc.67.1_spec_no.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wilson D. M., Baldwin R. B., Ariagno R. L. A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr. 1988 Oct;113(4):764–768. doi: 10.1016/s0022-3476(88)80398-6. [DOI] [PubMed] [Google Scholar]
  32. Wit J. M., van Unen H. Growth of infants with neonatal growth hormone deficiency. Arch Dis Child. 1992 Jul;67(7):920–924. doi: 10.1136/adc.67.7.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yeh T. F., McClenan D. A., Ajayi O. A., Pildes R. S. Metabolic rate and energy balance in infants with bronchopulmonary dysplasia. J Pediatr. 1989 Mar;114(3):448–451. doi: 10.1016/s0022-3476(89)80569-4. [DOI] [PubMed] [Google Scholar]
  34. Yeh T. F., Torre J. A., Rastogi A., Anyebuno M. A., Pildes R. S. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr. 1990 Aug;117(2 Pt 1):273–282. doi: 10.1016/s0022-3476(05)80547-5. [DOI] [PubMed] [Google Scholar]
  35. Yoder M. C., Jr, Chua R., Tepper R. Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis. 1991 May;143(5 Pt 1):1044–1048. doi: 10.1164/ajrccm/143.5_Pt_1.1044. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES